Concepedia

John McKolanis

JM

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

1986

Affiliations

University of Pittsburgh(Current)

Brigham and Women's Hospital

Emory University

UPMC Hillman Cancer Center

Harvard University

John McKolanis is an author at University of Pittsburgh specializing in oncology, medicine, and tumor-associated antigens.

Publications per year

1986–2023

14

Publications

14

MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study

Takashi Kimura, John McKolanis, Lynda Dzubinski et al. · Cancer Prevention Research · 2012 · 263 citations · Full text

Medicine, Immunology, Oncology +17

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Ramesh K. Ramanathan, Kenneth Lee, John McKolanis et al. · Cancer Immunology Immunotherapy · 2004 · 219 citations · Full text

Medicine, Immunology, Oncology +17

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

Andrew J. Lepisto, A. James Moser, Herbert J. Zeh et al. · PubMed · 2008 · 190 citations

Medicine, Immunology, Oncology +17

Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian Cancer

Daniel W. Cramer, Linda Titus‐Ernstoff, John McKolanis et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 137 citations

Medicine, Immunology, Oncology +17

T Cell–Dependent Antibody Responses against Aberrantly Expressed Cyclin B1 Protein in Patients with Cancer and Premalignant Disease

Hiroyuki Suzuki, Daniel Graziano, John McKolanis et al. · Clinical Cancer Research · 2005 · 113 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 14